MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
7 Defensive Stocks to Buy for a Bear Market
Tickers ADM CPB ED INCY
Tags NYSE:ADM,NYSE:CPB,NYSE:KO,NYSE:ED,NYSE:LLY,NYSE:KMB,NYSE:LMT,NASDAQ:INCY,NYSE:MKC Market News LLY
From InvestorPlace
3 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget
Tickers INCY META MU
Tags META MU INCY
From Motley Fool
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
Tickers EQ INCY LLY
Tags Benzinga Integrated Telecommunication Services Biotech
From Benzinga
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
Tickers ALNY DAWN EQRX FRLN
Tags DAWN Markets General
From Benzinga
Morning Brief: Top Financial Stories Dominating on Tuesday, June 14
Tickers AAPL AFLYY AMZN BRK-B
Tags META AAPL MSTR
From Benzinga
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
Tickers CNCE INCY LLY PFE
Tags PFE Alopecia Areata Biotech
From Benzinga
In a shaky economy, cash is king — and these S&P 500 companies have it, says Barclays
Tickers AAPL AKAM AMZN ATVI
Tags ATVI AAPL EFX
From MarketWatch
CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss
Tickers INCY LLY
Tags Movers Trading Ideas News
From Benzinga
2 Under-the-Radar Biotech Stocks to Buy in 2022
Tickers AXSM INCY JAZZ NVS
Tags AXSM JAZZ INCY
From Motley Fool
Was This Acquisition a Smart Move for GlaxoSmithKline?
Tickers GSK INCY SRRA
Tags GSK INCY Market News
From Motley Fool
Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted
Tickers CNCE INCY
Tags Trading Ideas Movers Health Care
From Benzinga
Why CTI Biopharma Stock Is Surging Today
Tickers CTIC INCY
Tags INCY CTIC Recent Press Releases
From Motley Fool
Amid Slowing Sales at Home, Innovent Biologics Stumbles Overseas
Tickers ASIA BGNE CHRS HCM
Tags INCY Markets HCM
From Benzinga
WHO head censored in China after criticizing zero-COVID policy, and U.S. cases up 52% from two weeks ago
Tickers EBS INCY LLY MSFT
Tags EBS MSFT INCY
From MarketWatch
FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) for Hospitalized Patients with COVID-19
Tickers INCY LLY
Tags INCY Health Care News
From Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Tickers ABUS AGIO ALDX ARGX
Tags FDA AZN NVS
From Benzinga
4 Analysts Have This to Say About Incyte
Tickers INCY
Tags BZI/AAR Analyst Ratings INCY
From Benzinga
Despite Q1 Earnings Miss, Incyte Shares Jump On Revised FY22 Sales Guidance
Tickers INCY
Tags Market News Large Cap Trading Ideas
From Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Tickers ACAD AQST BIIB BLTE
Tags FDA RIGL Market News
From Benzinga
Incyte: Q1 Earnings Insights
Tickers INCY
Tags INCY BZI/Recaps News
From Benzinga
Global Cord Blood Enters Therapy Market Via Cellenkos Acquisition For Over $600M
Tickers CO INCY
Tags M&A Penny Stocks Market News
From Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Tickers AGTC AMGN AMRN ATHX
Tags ATHX ILMN PRQR
From Benzinga
3 Nasdaq Stocks to Buy Now for Growth
Tickers AMZN AVGO BLK FTXL
Tags MU QCOM INCY
From InvestorPlace
EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting
Tickers INCY NVS
Tags Large Cap European Medicines Agency NVS
From Benzinga
How To Attend Incyte Q1 2022 Earnings Conference Call
Tickers INCY
Tags Benzinga Earnings Market News
From Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Tickers BGNE BTAI CCCC CTXR
Tags CTXR Top Stories Benzinga
From Benzinga
This Favorable Sign Appears On Incyte's Chart
Tickers INCY
Tags Benzinga Market News Markets
From Benzinga
Incyte's Ruxolitinib Shows Further Improvement In Facial, Total Body Re-pigmentation At 52 Weeks In Skin Disorder
Tickers INCY
Tags Briefs INCY General
From Benzinga
Incyte-Lilly's Olumiant Continue To Show Improved Scalp, Eyebrows, Eyelash Hair Regrowth At 52 Weeks
Tickers INCY LLY
Tags News Health Care General
From Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Tickers INCY NVO NVS
Tags Recent Press Releases Market News NVS
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story